# MTT for Children With ASD Who Have Gastrointestinal Disorders

> **NCT04182633** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Arizona State University** · enrollment: 50 (actual)

## Conditions studied

- Autism Spectrum Disorder
- Gastro-Intestinal Disorder
- Constipation
- Diarrhea

## Interventions

- **COMBINATION_PRODUCT:** vancomycin, Miralax, intestinal microbiota
- **COMBINATION_PRODUCT:** placebo vancomycin, Miralax, placebo intestinal microbiota

## Key facts

- **NCT ID:** NCT04182633
- **Lead sponsor:** Arizona State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-11-15
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04182633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04182633, "MTT for Children With ASD Who Have Gastrointestinal Disorders". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04182633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*